CVRx (United States)
company in Minneapolis, United States
CVRX Nasdaq
SEC CIK 1235912
Follow CVRx (United States)
Weekly email: filings, results
Revenue, last quarter
$13.8M
−5.8% vs same quarter last year
Net income
−$14.2M
−10% vs same quarter last year
EPS, diluted
−$0.52
−6.1% vs same quarter last year
Operating cash flow
−$10.9M
−12.2% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $56.7M | −$53.3M |
| FY24 | $51.3M | −$60M |
| FY23 | $39.3M | −$41.2M |
| FY22 | $22.5M | −$41.4M |
| FY21 | $13M | −$43.1M |
| FY20 | $6.1M | −$14.1M |
| FY19 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 85.3% | −90.5% | −94.1% |
| FY24 | 83.8% | −116% | −116.9% |
| FY23 | 84.1% | −109.7% | −104.8% |
| FY22 | 77.8% | −189.3% | −184.4% |
| FY21 | 72.1% | −199.2% | −330.5% |
| FY20 | 76.2% | −190.2% | −233.1% |
| FY19 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$40.8M |
| FY24 | −$40.5M |
| FY23 | −$39.6M |
| FY22 | −$43.4M |
| FY21 | −$28.9M |
| FY20 | −$16.4M |
| FY19 | - |
- CVRx (United States)
- Healthcare median
Show the numbers
| Year | CVRx (United States) | Healthcare median |
|---|---|---|
| FY25 | −94.1% | −30.6% |
| FY24 | −116.9% | −47% |
| FY23 | −104.8% | −58% |
| FY22 | −184.4% | −80.4% |
| FY21 | −330.5% | −71.8% |
| FY20 | −233.1% | −62.2% |
| FY19 | - | −46.2% |